China Money Network
Login
Join

Chinese Biotech Start-Up Stemirna Therapeutics Raises $14M Series A Round

  • August 12, 2019 — 20:03 CST

This Data Is Locked!

This area is available only to Subscribers.

Stemirna Therapeutics, a Chinese biotech start-up focusing on RNA technology-based drug development, has raised nearly RMB100 million (US$14.16 million) in a serious A round of... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: